These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39324142)

  • 1. Autoantibody profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study.
    Li S; Xu D; Murakoshi N; Yuan Z; Imaoka T; Tajiri K
    Front Immunol; 2024; 15():1423622. PubMed ID: 39324142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
    Müller-Jensen L; Knauss S; Ginesta Roque L; Schinke C; Maierhof SK; Bartels F; Finke C; Rentzsch K; Ulrich C; Mohr R; Stenzel W; Endres M; Boehmerle W; Huehnchen P
    Front Immunol; 2023; 14():1108116. PubMed ID: 36845122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
    Ghosh N; Postow M; Zhu C; Jannat-Khah D; Li QZ; Vitone G; Chan KK; Bass AR
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key immune-related genes and potential therapeutic targets in immune checkpoint inhibitor-associated myocarditis.
    Qu S; Zhang J; Wang K; Zhou Y
    Postgrad Med J; 2024 Sep; ():. PubMed ID: 39251231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
    Ravi P; Freeman D; Thomas J; Ravi A; Mantia C; McGregor BA; Berchuck JE; Epstein I; Budde P; Ahangarian Abhari B; Rupieper E; Gajewski J; Schubert AS; Kilian AL; Bräutigam M; Zucht HD; Sonpavde G
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309723
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA sequencing reveals the altered innate immunity in immune checkpoint inhibitor-related myocarditis.
    Lou B; Guo M; Zheng T; Liu J; Wang C; Chen T; Chen F; Fan X; Gao S; Liang X; Qiang H; Li L; Zhou B; Yuan Z; She J
    Immunology; 2024 Jun; 172(2):235-251. PubMed ID: 38425094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.
    Liu Q; Yu Y; Lin J; Wang Y; Ai L; Li Q; Wu W; Jin H; Li S; Liu M; Yu S; Liu T
    Eur J Cancer; 2021 Nov; 157():10-20. PubMed ID: 34464781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
    Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
    Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
    Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
    Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor-associated myocarditis.
    Yu J; Long B; Li Z; Tian X; Li D; Long J; Wang Y; Chen Y; Zhang F; Liu H; Qian C; Shan J
    Cardiovasc Res; 2024 Oct; 120(12):1442-1455. PubMed ID: 38850163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis.
    Drobni ZD; Zafar A; Zubiri L; Zlotoff DA; Alvi RM; Lee C; Hartmann S; Gilman HK; Villani AC; Nohria A; Groarke JD; Sullivan RJ; Reynolds KL; Zhang L; Neilan TG
    J Am Heart Assoc; 2020 Dec; 9(23):e018306. PubMed ID: 33190570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart.
    Munir AZ; Gutierrez A; Qin J; Lichtman AH; Moslehi JJ
    Nat Rev Cancer; 2024 Aug; 24(8):540-553. PubMed ID: 38982146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.
    Wang F; Sun X; Qin S; Hua H; Liu X; Yang L; Yang M
    Chin Clin Oncol; 2020 Apr; 9(2):16. PubMed ID: 32279526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review.
    Lehmann LH; Cautela J; Palaskas N; Baik AH; Meijers WC; Allenbach Y; Alexandre J; Rassaf T; Müller OJ; Aras M; Asnani AH; Deswal A; Laufer-Perl M; Thuny F; Kerneis M; Hayek SS; Ederhy S; Salem JE; Moslehi JJ
    JAMA Cardiol; 2021 Nov; 6(11):1329-1337. PubMed ID: 34232253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
    Fenioux C; Abbar B; Boussouar S; Bretagne M; Power JR; Moslehi JJ; Gougis P; Amelin D; Dechartres A; Lehmann LH; Courand PY; Cautela J; Alexandre J; Procureur A; Rozes A; Leonard-Louis S; Qin J; ; Cheynier R; Charmeteau-De Muylder B; Redheuil A; Tubach F; Cadranel J; Milon A; Ederhy S; Similowski T; Johnson DB; Pizzo I; Catalan T; Benveniste O; Hayek SS; Allenbach Y; Rosenzwajg M; Dolladille C; Salem JE
    Nat Med; 2023 Dec; 29(12):3100-3110. PubMed ID: 37884625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
    Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; He R; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
    Circulation; 2024 Jan; 149(1):48-66. PubMed ID: 37746718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.
    Hamada N; Maeda A; Takase-Minegishi K; Kirino Y; Sugiyama Y; Namkoong H; Horita N; Yoshimi R; Nakajima H;
    Front Immunol; 2021; 12():803410. PubMed ID: 34938300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.